Hepatitis C virus (HCV) is one of the major causes of liver disease and a potential cause of substantial morbidity and mortality worldwide. HCV genotype 4 is responsible for more than 90% of chronic HCV infection in Egypt. Aim: estimation of the response rate and detection of the effect of treatment of CHC patients on degree of fibrosis. Patients and method: 90 patients included, 30 receving interferon containing regimen and 60 receiving interferon free. Conclusion: DAAS make a revolution in HCV treatment.
Motawea, I. .., El-Sagheir, G., Matta, R., & Ibrahim, S. (2020). Effect of Treatment of Chronic Hepatitis C Patients by new Antiviral Drugs. Minia Journal of Medical Research, 31(4), 152-157. doi: 10.21608/mjmr.2022.217559
MLA
Ibrahim . A Motawea; Ghada M. El-Sagheir; Ragaa A. Matta; Sharehan A. Ibrahim. "Effect of Treatment of Chronic Hepatitis C Patients by new Antiviral Drugs". Minia Journal of Medical Research, 31, 4, 2020, 152-157. doi: 10.21608/mjmr.2022.217559
HARVARD
Motawea, I. .., El-Sagheir, G., Matta, R., Ibrahim, S. (2020). 'Effect of Treatment of Chronic Hepatitis C Patients by new Antiviral Drugs', Minia Journal of Medical Research, 31(4), pp. 152-157. doi: 10.21608/mjmr.2022.217559
VANCOUVER
Motawea, I. .., El-Sagheir, G., Matta, R., Ibrahim, S. Effect of Treatment of Chronic Hepatitis C Patients by new Antiviral Drugs. Minia Journal of Medical Research, 2020; 31(4): 152-157. doi: 10.21608/mjmr.2022.217559
)
View on SCiNiTO